Parkman Healthcare Partners LLC Verastem, Inc. Transaction History

Parkman Healthcare Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $194,570 - $349,081	-190,755 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.06 - $2.1 $7,868 - $15,588	7,423 Added 4.05%	190,755 $269,000
Q4 2021 Feb 11, 2022	BUY	$2.05 - $3.2 $15,446 - $24,112	7,535 Added 4.29%	183,332 $376,000
Q3 2021 Nov 12, 2021	BUY	$2.54 - $4.07 $127,000 - $203,500	50,000 Added 39.75%	175,797 $541,000
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $323,298 - $610,115	125,797 New	125,797 $512,000
Q1 2021 May 14, 2021	SELL	$1.9 - $2.82 $477,753 - $709,086	-251,449 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.15 - $2.4 $289,166 - $603,477	251,449 New	251,449 $536,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.17B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.